| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | LPAR3 OR7E24 OR4F4 MC1R MC2R ADGRV1 CHRM1 PTH1R FFAR4 OR4D2 OR10D4P OR2K2 OR4F5 TAS2R4 OR6C76 OR6C1 OR6C75 OR6J1 OR4F17 ADGRF1 CNR1 OR2H2 OR5P2 VIPR1 OR8J2 NPY6R HTR1D HTR2B OR4N5 OR6S1 GPR33 OR6C74 GRM7 OR10X1 CCKBR OR52J3 OR6C2 OR6C4 OR4C12 LPAR2 OR4B1 OR4K5 RXFP1 ACKR1 GABBR1 OR4F15 | 3.27e-19 | 884 | 216 | 46 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | LPAR3 OR7E24 OR4F4 MC1R MC2R ADGRV1 CHRM1 PTH1R CHRNB3 FFAR4 OR4D2 OR10D4P OR2K2 OR4F5 TAS2R4 KLRF1 OR6C76 OR6C1 OR6C75 OR6J1 OR4F17 ANXA9 ADGRF1 KLRB1 CNR1 OR2H2 OR5P2 VIPR1 OR8J2 NPY6R HTR1D HTR2B OR4N5 OR6S1 GPR33 OR6C74 GRM7 OR10X1 CCKBR OR52J3 OR6C2 OR6C4 SCARB2 OR4C12 LPAR2 OR4B1 OR4K5 RXFP1 ACKR1 M6PR GABBR1 EPHA4 OR4F15 | 9.89e-17 | 1353 | 216 | 53 | GO:0004888 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR7E24 OR4F4 OR4D2 OR10D4P OR2K2 OR4F5 OR6C76 OR6C1 OR6C75 OR6J1 OR4F17 OR2H2 OR5P2 OR8J2 OR4N5 OR6S1 OR6C74 OR10X1 OR52J3 OR6C2 OR6C4 OR4C12 OR4B1 OR4K5 OR4F15 | 8.97e-12 | 431 | 216 | 25 | GO:0004984 |
| GeneOntologyMolecularFunction | transporter activity | SLC46A2 CNNM2 SLC36A1 SLC7A13 PKD1L2 ABCA10 SLC39A8 CHRNB3 KCNK18 SLC13A4 SLC12A9 SLC22A14 SCN4A ATP2C2 SLC35A2 ATP11C SLC5A10 RASA3 ABCC5 APOB SLC34A3 CYB561A3 SLC7A6 GRM7 AQP1 MCOLN1 SLC9C2 SLC1A2 SLC1A6 RHCE SLC7A1 SLC35A3 CACNA2D4 ATP2C1 SLC12A3 SLC36A3 ABCC12 M6PR SLC4A11 SLC35B1 SLC22A31 | 3.75e-10 | 1289 | 216 | 41 | GO:0005215 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC46A2 SLC36A1 SLC7A13 ABCA10 SLC39A8 SLC13A4 SLC12A9 ATP2C2 SLC35A2 SLC5A10 ABCC5 SLC34A3 CYB561A3 SLC7A6 SLC9C2 SLC1A2 SLC1A6 SLC35A3 ATP2C1 SLC12A3 SLC36A3 ABCC12 SLC4A11 SLC35B1 | 4.42e-10 | 477 | 216 | 24 | GO:0022804 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC46A2 CNNM2 SLC36A1 SLC7A13 PKD1L2 ABCA10 SLC39A8 CHRNB3 KCNK18 SLC13A4 SLC12A9 SLC22A14 SCN4A ATP2C2 SLC35A2 SLC5A10 RASA3 ABCC5 SLC34A3 CYB561A3 SLC7A6 GRM7 AQP1 MCOLN1 SLC9C2 SLC1A2 SLC1A6 RHCE SLC7A1 SLC35A3 CACNA2D4 ATP2C1 SLC12A3 SLC36A3 ABCC12 SLC4A11 SLC35B1 SLC22A31 | 1.31e-09 | 1180 | 216 | 38 | GO:0022857 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC46A2 SLC36A1 SLC7A13 SLC39A8 SLC13A4 SLC12A9 SLC35A2 SLC5A10 SLC34A3 SLC7A6 SLC9C2 SLC1A2 SLC1A6 SLC35A3 SLC12A3 SLC36A3 SLC4A11 SLC35B1 | 4.03e-09 | 296 | 216 | 18 | GO:0015291 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CNNM2 PKD1L2 SLC39A8 KCNK18 SLC13A4 SLC12A9 SCN4A ATP2C2 SLC5A10 RASA3 SLC34A3 GRM7 AQP1 MCOLN1 SLC9C2 SLC1A2 SLC1A6 CACNA2D4 ATP2C1 SLC12A3 SLC4A11 | 3.76e-08 | 465 | 216 | 21 | GO:0046873 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CNNM2 SLC36A1 PKD1L2 SLC39A8 KCNK18 SLC13A4 SLC12A9 SCN4A ATP2C2 SLC5A10 RASA3 SLC34A3 GRM7 AQP1 MCOLN1 SLC9C2 SLC1A2 SLC1A6 RHCE CACNA2D4 ATP2C1 SLC12A3 SLC36A3 SLC4A11 | 8.76e-08 | 627 | 216 | 24 | GO:0022890 |
| GeneOntologyMolecularFunction | symporter activity | SLC46A2 SLC36A1 SLC39A8 SLC13A4 SLC12A9 SLC5A10 SLC34A3 SLC1A2 SLC1A6 SLC12A3 SLC36A3 SLC4A11 | 8.80e-08 | 150 | 216 | 12 | GO:0015293 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CNNM2 SLC36A1 PKD1L2 SLC39A8 CHRNB3 KCNK18 SLC13A4 SLC12A9 SCN4A ATP2C2 SLC5A10 RASA3 SLC34A3 GRM7 AQP1 MCOLN1 SLC9C2 SLC1A2 SLC1A6 CACNA2D4 ATP2C1 SLC12A3 SLC36A3 SLC4A11 | 2.51e-07 | 664 | 216 | 24 | GO:0008324 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | SLC36A1 SLC39A8 SLC13A4 SLC12A9 SLC5A10 SLC34A3 SLC1A2 SLC1A6 SLC12A3 SLC36A3 | 6.79e-07 | 119 | 216 | 10 | GO:0015294 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CNNM2 SLC36A1 PKD1L2 SLC39A8 KCNK18 SLC13A4 SLC12A9 SCN4A ATP2C2 SLC5A10 RASA3 ABCC5 SLC34A3 GRM7 AQP1 MCOLN1 SLC9C2 SLC1A2 SLC1A6 RHCE CACNA2D4 ATP2C1 SLC12A3 SLC36A3 SLC4A11 | 7.58e-07 | 758 | 216 | 25 | GO:0015318 |
| GeneOntologyMolecularFunction | UDP-galactose transmembrane transporter activity | 1.25e-06 | 3 | 216 | 3 | GO:0005459 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC46A2 SLC36A1 SLC7A13 SLC39A8 SLC22A14 ABCC5 SLC7A6 SLC1A2 SLC1A6 SLC7A1 SLC35A3 SLC36A3 SLC4A11 SLC35B1 | 3.99e-06 | 293 | 216 | 14 | GO:0008514 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CNNM2 SLC36A1 PKD1L2 SLC39A8 CHRNB3 KCNK18 SLC13A4 SLC12A9 SCN4A ATP2C2 SLC5A10 RASA3 SLC34A3 GRM7 AQP1 MCOLN1 SLC9C2 SLC1A2 SLC1A6 CACNA2D4 ATP2C1 SLC12A3 SLC36A3 SLC4A11 | 5.61e-06 | 793 | 216 | 24 | GO:0015075 |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 1.16e-05 | 71 | 216 | 7 | GO:0015179 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SLC13A4 SCN4A SLC5A10 SLC34A3 MCOLN1 SLC9C2 SLC1A2 SLC1A6 SLC12A3 SLC4A11 | 1.77e-05 | 171 | 216 | 10 | GO:0015081 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC36A1 SLC39A8 SLC13A4 SLC12A9 ATP2C2 SLC5A10 SLC34A3 SLC9C2 SLC1A2 SLC1A6 ATP2C1 SLC12A3 SLC36A3 | 2.59e-05 | 301 | 216 | 13 | GO:0022853 |
| GeneOntologyMolecularFunction | P-type manganese transporter activity | 1.16e-04 | 2 | 216 | 2 | GO:0140613 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.46e-04 | 105 | 216 | 7 | GO:0015171 | |
| GeneOntologyMolecularFunction | pyrimidine nucleotide-sugar transmembrane transporter activity | 1.93e-04 | 11 | 216 | 3 | GO:0015165 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 2.47e-04 | 81 | 216 | 6 | GO:0015370 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 2.56e-04 | 29 | 216 | 4 | GO:0005416 | |
| GeneOntologyMolecularFunction | nucleotide-sugar transmembrane transporter activity | 4.16e-04 | 14 | 216 | 3 | GO:0005338 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 4.40e-04 | 59 | 216 | 5 | GO:1901505 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 4.40e-04 | 59 | 216 | 5 | GO:0015932 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 6.19e-04 | 133 | 216 | 7 | GO:0008528 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibitor activity | 6.89e-04 | 4 | 216 | 2 | GO:0010855 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 7.65e-04 | 100 | 216 | 6 | GO:0030594 | |
| GeneOntologyMolecularFunction | antiporter activity | 7.70e-04 | 138 | 216 | 7 | GO:0015297 | |
| GeneOntologyMolecularFunction | disordered domain specific binding | 8.14e-04 | 39 | 216 | 4 | GO:0097718 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 8.38e-04 | 140 | 216 | 7 | GO:0001653 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 9.86e-04 | 41 | 216 | 4 | GO:0015175 | |
| GeneOntologyMolecularFunction | high-affinity L-glutamate transmembrane transporter activity | 1.14e-03 | 5 | 216 | 2 | GO:0005314 | |
| GeneOntologyMolecularFunction | cyclase inhibitor activity | 1.14e-03 | 5 | 216 | 2 | GO:0010852 | |
| GeneOntologyMolecularFunction | lysophosphatidic acid receptor activity | 1.14e-03 | 5 | 216 | 2 | GO:0070915 | |
| GeneOntologyMolecularFunction | glutamate:sodium symporter activity | 1.14e-03 | 5 | 216 | 2 | GO:0015501 | |
| GeneOntologyMolecularFunction | G-protein alpha-subunit binding | 1.18e-03 | 43 | 216 | 4 | GO:0001965 | |
| GeneOntologyMolecularFunction | transition metal ion transmembrane transporter activity | 1.29e-03 | 44 | 216 | 4 | GO:0046915 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.30e-03 | 151 | 216 | 7 | GO:0015085 | |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor activity | 1.65e-03 | 22 | 216 | 3 | GO:0004993 | |
| GeneOntologyMolecularFunction | amino acid:proton symporter activity | 1.70e-03 | 6 | 216 | 2 | GO:0005280 | |
| GeneOntologyMolecularFunction | melanocortin receptor activity | 1.70e-03 | 6 | 216 | 2 | GO:0004977 | |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 1.88e-03 | 23 | 216 | 3 | GO:0015464 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 2.07e-03 | 83 | 216 | 5 | GO:0015101 | |
| GeneOntologyMolecularFunction | L-proline transmembrane transporter activity | 2.36e-03 | 7 | 216 | 2 | GO:0015193 | |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 3.71e-03 | 29 | 216 | 3 | GO:0015216 | |
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 3.99e-03 | 9 | 216 | 2 | GO:0015379 | |
| GeneOntologyMolecularFunction | adenylate cyclase regulator activity | 3.99e-03 | 9 | 216 | 2 | GO:0010854 | |
| GeneOntologyMolecularFunction | L-lysine transmembrane transporter activity | 3.99e-03 | 9 | 216 | 2 | GO:0015189 | |
| GeneOntologyMolecularFunction | L-alanine transmembrane transporter activity | 3.99e-03 | 9 | 216 | 2 | GO:0015180 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | LPAR3 OR7E24 OR4F4 MC1R MC2R ADGRV1 CHRM1 ADCY1 PTH1R FFAR4 OR4D2 OR10D4P OR2K2 OR4F5 TAS2R4 OR6C76 OR6C1 OR6C75 OR6J1 OR4F17 ADGRF1 CNR1 OR2H2 OR5P2 VIPR1 OR8J2 NPY6R HTR1D HTR2B OR4N5 OR6S1 GPR33 OR6C74 GRM7 OR10X1 CCKBR OR52J3 OR6C2 OR6C4 OR4C12 LPAR2 OR4B1 OR4K5 RXFP1 ACKR1 GABBR1 OR4F15 | 3.57e-13 | 1395 | 213 | 47 | GO:0007186 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR7E24 OR4F4 FFAR4 OR4D2 OR10D4P OR2K2 OR4F5 TAS2R4 OR6C76 OR6C1 OR6C75 OR6J1 OR4F17 OR2H2 OR5P2 OR8J2 OR4N5 OR6S1 OR6C74 LBP OR10X1 OR52J3 OR6C2 OR6C4 OR4C12 OR4B1 OR4K5 OR4F15 | 1.09e-12 | 524 | 213 | 28 | GO:0009593 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR7E24 OR4F4 FFAR4 OR4D2 OR10D4P OR2K2 OR4F5 TAS2R4 OR6C76 OR6C1 OR6C75 OR6J1 OR4F17 OR2H2 OR5P2 OR8J2 OR4N5 OR6S1 OR6C74 OR10X1 OR52J3 OR6C2 OR6C4 OR4C12 OR4B1 OR4K5 OR4F15 | 1.10e-12 | 485 | 213 | 27 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR7E24 OR4F4 ADGRV1 FFAR4 OR4D2 OR10D4P OR2K2 OR4F5 TAS2R4 OR6C76 OR6C1 OR6C75 OR6J1 OR4F17 OR2H2 OR5P2 OR8J2 OR4N5 OR6S1 OR6C74 OR10X1 OR52J3 CACNA2D4 OR6C2 OR6C4 OR4C12 OR4B1 OR4K5 OR4F15 | 2.35e-12 | 582 | 213 | 29 | GO:0050906 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR7E24 OR4F4 OR4D2 OR10D4P OR2K2 OR4F5 OR6C76 OR6C1 OR6C75 OR6J1 UGT2A1 OR4F17 OR2H2 OR5P2 OR8J2 OR4N5 OR6S1 OR6C74 OR10X1 OR52J3 OR6C2 OR6C4 OR4C12 OR4B1 OR4K5 OR4F15 | 2.70e-12 | 465 | 213 | 26 | GO:0007608 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR7E24 OR4F4 FFAR4 OR4D2 OR10D4P OR2K2 OR4F5 TAS2R4 OR6C76 OR6C1 OR6C75 OR6J1 UGT2A1 OR4F17 OR2H2 OR5P2 OR8J2 OR4N5 OR6S1 OR6C74 OR10X1 OR52J3 OR6C2 OR6C4 OR4C12 OR4B1 OR4K5 OR4F15 | 3.06e-12 | 547 | 213 | 28 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR7E24 OR4F4 OR4D2 OR10D4P OR2K2 OR4F5 OR6C76 OR6C1 OR6C75 OR6J1 OR4F17 OR2H2 OR5P2 OR8J2 OR4N5 OR6S1 OR6C74 OR10X1 OR52J3 OR6C2 OR6C4 OR4C12 OR4B1 OR4K5 OR4F15 | 3.46e-12 | 432 | 213 | 25 | GO:0050911 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR7E24 OR4F4 ADGRV1 PKD1L2 FFAR4 OR4D2 OR10D4P OR2K2 OR4F5 TAS2R4 OR6C76 OR6C1 OR6C75 OR6J1 OR4F17 OR2H2 OR5P2 OR8J2 OR4N5 OR6S1 OR6C74 LBP OR10X1 OR52J3 CACNA2D4 OR6C2 OR6C4 OR4C12 OR4B1 OR4K5 OR4F15 | 1.77e-11 | 722 | 213 | 31 | GO:0051606 |
| GeneOntologyBiologicalProcess | sensory perception | OR7E24 OR4F4 MC1R ADGRV1 FFAR4 OR4D2 OR10D4P OR2K2 OR4F5 TAS2R4 OTOGL OR6C76 OR6C1 OR6C75 OR6J1 UGT2A1 OR4F17 NIPBL OR2H2 OR5P2 OR8J2 OR4N5 OR6S1 OR6C74 GRM7 AQP1 OR10X1 OR52J3 CACNA2D4 HMCN1 OR6C2 OR6C4 SCARB2 OR4C12 OR4B1 OR4K5 OR4F15 | 9.03e-11 | 1072 | 213 | 37 | GO:0007600 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 1.23e-08 | 61 | 213 | 9 | GO:0007187 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | LPAR3 MC1R MC2R CHRM1 ADCY1 PTH1R FFAR4 ADGRF1 CNR1 VIPR1 HTR1D GRM7 LPAR2 RXFP1 GABBR1 | 3.12e-07 | 286 | 213 | 15 | GO:0007188 |
| GeneOntologyBiologicalProcess | UDP-galactose transmembrane transport | 1.09e-06 | 3 | 213 | 3 | GO:0072334 | |
| GeneOntologyBiologicalProcess | organic anion transport | SLC46A2 SLC36A1 SLC7A13 SLC39A8 SLC22A14 SLC35A2 ABCC5 SLC7A6 GRM7 SELENON SLC1A2 SLC1A6 SLC7A1 SLC35A3 SLC36A3 GABBR1 SLC4A11 SLC35B1 | 7.21e-06 | 515 | 213 | 18 | GO:0015711 |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 3.09e-05 | 191 | 213 | 10 | GO:0007189 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | LPAR3 RELN CNNM2 SLC36A1 PKD1L2 CHRM1 SLC39A8 CHRNB3 KCNK18 SLC13A4 SLC12A9 SCN4A ATP2C2 ATP11C CNR1 SLC5A10 HTR2B ABCC5 SLC34A3 AQP1 SELENON MCOLN1 SLC9C2 SLC1A2 SLC1A6 CACNA2D4 ATP2C1 SLC12A3 SLC36A3 SLC4A11 SLC22A31 | 3.32e-05 | 1374 | 213 | 31 | GO:0006811 |
| GeneOntologyBiologicalProcess | neutral amino acid transport | 3.56e-05 | 60 | 213 | 6 | GO:0015804 | |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | SLC36A1 SLC7A13 ABCC5 SLC7A6 SELENON SLC1A2 SLC1A6 SLC7A1 SLC36A3 | 5.11e-05 | 163 | 213 | 9 | GO:1905039 |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | SLC36A1 SLC7A13 ABCC5 SLC7A6 SELENON SLC1A2 SLC1A6 SLC7A1 SLC36A3 | 6.17e-05 | 167 | 213 | 9 | GO:1903825 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CNNM2 SLC36A1 PKD1L2 SLC39A8 KCNK18 SLC13A4 SLC12A9 SCN4A ATP2C2 SLC5A10 HTR2B ABCC5 SLC34A3 AQP1 SELENON MCOLN1 SLC9C2 RHCE CACNA2D4 ATP2C1 SLC12A3 SLC36A3 SLC4A11 | 8.71e-05 | 922 | 213 | 23 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | RELN CNNM2 SLC36A1 PKD1L2 SLC39A8 CHRNB3 KCNK18 SLC13A4 SLC12A9 SCN4A ATP2C2 ATP11C SLC5A10 HTR2B ABCC5 SLC34A3 AQP1 SELENON MCOLN1 SLC9C2 SLC1A2 CACNA2D4 ATP2C1 SLC12A3 SLC36A3 SLC4A11 | 8.95e-05 | 1115 | 213 | 26 | GO:0034220 |
| GeneOntologyBiologicalProcess | L-amino acid transport | 1.31e-04 | 108 | 213 | 7 | GO:0015807 | |
| GeneOntologyBiologicalProcess | amino acid transport | SLC36A1 SLC7A13 SLC7A6 GRM7 SLC1A2 SLC1A6 SLC7A1 SLC36A3 GABBR1 | 2.01e-04 | 195 | 213 | 9 | GO:0006865 |
| GeneOntologyBiologicalProcess | regulation of carbohydrate catabolic process | 2.06e-04 | 82 | 213 | 6 | GO:0043470 | |
| GeneOntologyBiologicalProcess | manganese ion transmembrane transport | 2.23e-04 | 12 | 213 | 3 | GO:0071421 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleotide-sugar transmembrane transport | 2.23e-04 | 12 | 213 | 3 | GO:0090481 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 2.52e-04 | 120 | 213 | 7 | GO:0003333 | |
| GeneOntologyBiologicalProcess | L-alpha-amino acid transmembrane transport | 2.85e-04 | 87 | 213 | 6 | GO:1902475 | |
| GeneOntologyBiologicalProcess | nucleotide-sugar transmembrane transport | 2.88e-04 | 13 | 213 | 3 | GO:0015780 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CNNM2 SLC36A1 PKD1L2 SLC39A8 KCNK18 SLC13A4 SLC12A9 SCN4A ATP2C2 SLC5A10 HTR2B ABCC5 SLC34A3 AQP1 SELENON MCOLN1 SLC9C2 CACNA2D4 ATP2C1 SLC12A3 SLC36A3 SLC4A11 | 3.14e-04 | 942 | 213 | 22 | GO:0098655 |
| GeneOntologyBiologicalProcess | intracellular manganese ion homeostasis | 3.16e-04 | 3 | 213 | 2 | GO:0030026 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CNNM2 SLC36A1 PKD1L2 SLC39A8 KCNK18 SLC13A4 SLC12A9 SCN4A ATP2C2 SLC5A10 HTR2B ABCC5 SLC34A3 AQP1 SELENON MCOLN1 SLC9C2 RHCE CACNA2D4 ATP2C1 SLC12A3 SLC36A3 SLC4A11 | 3.60e-04 | 1017 | 213 | 23 | GO:0098660 |
| GeneOntologyBiologicalProcess | manganese ion transport | 3.63e-04 | 14 | 213 | 3 | GO:0006828 | |
| GeneOntologyBiologicalProcess | behavior | RELN MC1R SRF ADCY1 PTCHD1 SYNJ1 TRMT1L ADGRF1 CNR1 HTR1D CWH43 HTR2B ID2 ALS2 REN GRM7 SLC1A2 CCKBR CSMD1 TP53 EPHA4 | 3.83e-04 | 891 | 213 | 21 | GO:0007610 |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | CNNM2 PTH1R SLC39A8 SLC12A9 ATP2C2 PKHD1 CNR1 HTR2B CYB561A3 SELENON MCOLN1 SLC9C2 RHCE CCKBR ATP2C1 SLC12A3 TP53 SLC4A11 | 3.98e-04 | 705 | 213 | 18 | GO:0055080 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DCHS2 ITGA4 DSCAML1 CD177 FAT3 PCDHB12 PCDHAC1 PCDHA1 PCDH20 ATP2C1 HMCN1 | 4.32e-04 | 313 | 213 | 11 | GO:0098742 |
| GeneOntologyBiologicalProcess | carbohydrate derivative transport | 4.84e-04 | 96 | 213 | 6 | GO:1901264 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | CNNM2 PTH1R SLC39A8 SLC12A9 ATP2C2 PKHD1 CNR1 HTR2B CYB561A3 SELENON MCOLN1 SLC9C2 RHCE CCKBR ATP2C1 SLC12A3 TP53 SLC4A11 | 4.86e-04 | 717 | 213 | 18 | GO:0050801 |
| GeneOntologyCellularComponent | ankyrin-1 complex | 1.34e-04 | 10 | 222 | 3 | GO:0170014 | |
| GeneOntologyCellularComponent | apical part of cell | SLC36A1 SLC7A13 PTH1R SLC39A8 PKHD1 SLC5A10 NUMA1 ABCC5 REN SLC34A3 CUBN AQP1 CEP164 SLC7A1 SLC12A3 MUC1 SLC4A11 | 2.09e-04 | 592 | 222 | 17 | GO:0045177 |
| Domain | 7tm_1 | LPAR3 OR7E24 OR4F4 MC1R MC2R CHRM1 FFAR4 OR4D2 OR2K2 OR4F5 OR6C76 OR6C1 OR6C75 OR6J1 OR4F17 CNR1 OR2H2 OR5P2 HTR1D HTR2B OR4N5 OR6S1 GPR33 OR6C74 OR10X1 CCKBR OR52J3 OR6C2 OR6C4 OR4C12 LPAR2 OR4B1 OR4K5 RXFP1 OR4F15 | 8.79e-14 | 677 | 216 | 35 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | LPAR3 OR7E24 OR4F4 MC1R MC2R CHRM1 FFAR4 OR4D2 OR2K2 OR4F5 OR6C76 OR6C1 OR6C75 OR6J1 OR4F17 CNR1 OR2H2 OR5P2 HTR1D HTR2B OR4N5 OR6S1 GPR33 OR6C74 OR10X1 CCKBR OR52J3 OR6C2 OR6C4 OR4C12 LPAR2 OR4B1 OR4K5 RXFP1 OR4F15 | 1.24e-13 | 685 | 216 | 35 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | LPAR3 OR7E24 OR4F4 MC1R MC2R CHRM1 FFAR4 OR4D2 OR2K2 OR4F5 OR6C76 OR6C1 OR6C75 OR6J1 OR4F17 CNR1 OR2H2 OR5P2 HTR1D HTR2B OR4N5 OR6S1 GPR33 OR6C74 OR10X1 CCKBR OR52J3 OR6C2 OR6C4 OR4C12 LPAR2 OR4B1 OR4K5 RXFP1 OR4F15 | 1.60e-13 | 691 | 216 | 35 | PS50262 |
| Domain | GPCR_Rhodpsn | LPAR3 OR7E24 OR4F4 MC1R MC2R CHRM1 FFAR4 OR4D2 OR2K2 OR4F5 OR6C76 OR6C1 OR6C75 OR6J1 OR4F17 CNR1 OR2H2 OR5P2 HTR1D HTR2B OR4N5 OR6S1 GPR33 OR6C74 OR10X1 CCKBR OR52J3 OR6C2 OR6C4 OR4C12 LPAR2 OR4B1 OR4K5 RXFP1 OR4F15 | 1.67e-13 | 692 | 216 | 35 | IPR000276 |
| Domain | GPCR_Rhodpsn_7TM | LPAR3 OR7E24 OR4F4 MC1R MC2R CHRM1 FFAR4 OR4D2 OR2K2 OR4F5 OR6C76 OR6C1 OR6C75 OR4F17 CNR1 OR2H2 OR5P2 HTR1D HTR2B OR4N5 OR6S1 GPR33 OR6C74 OR10X1 CCKBR OR52J3 OR6C2 OR6C4 OR4C12 LPAR2 OR4B1 OR4K5 RXFP1 OR4F15 | 3.52e-13 | 670 | 216 | 34 | IPR017452 |
| Domain | Olfact_rcpt | OR7E24 OR4F4 OR4D2 OR2K2 OR4F5 OR6C76 OR6C1 OR6C75 OR6J1 OR4F17 OR2H2 OR5P2 OR4N5 OR6S1 OR6C74 OR10X1 OR52J3 OR6C2 OR6C4 OR4C12 OR4B1 OR4K5 OR4F15 | 1.97e-10 | 393 | 216 | 23 | IPR000725 |
| Domain | AA-permease/SLC12A_dom | 4.43e-06 | 22 | 216 | 5 | IPR004841 | |
| Domain | AA_permease | 4.43e-06 | 22 | 216 | 5 | PF00324 | |
| Domain | ARM-type_fold | SMG1 PSME4 AP2A2 PI4KA ANKAR GCN1 NIPBL ZYG11A NCAPD3 TNPO2 ZYG11B APOB PPP6R1 PPP6R2 | 4.28e-05 | 339 | 216 | 14 | IPR016024 |
| Domain | SEA | 1.08e-04 | 22 | 216 | 4 | PF01390 | |
| Domain | SEA | 1.30e-04 | 23 | 216 | 4 | PS50024 | |
| Domain | SEA_dom | 1.30e-04 | 23 | 216 | 4 | IPR000082 | |
| Domain | TRC8_N | 1.33e-04 | 2 | 216 | 2 | PF13705 | |
| Domain | TRC8_N_dom | 1.33e-04 | 2 | 216 | 2 | IPR025754 | |
| Domain | P-type_ATPase_IIA_PMR1 | 1.33e-04 | 2 | 216 | 2 | IPR006413 | |
| Domain | HEAT_REPEAT | 1.58e-04 | 70 | 216 | 6 | PS50077 | |
| Domain | ARM-like | SMG1 PSME4 AP2A2 ANKAR GCN1 NIPBL ZYG11A NCAPD3 TNPO2 ZYG11B PPP6R2 | 3.19e-04 | 270 | 216 | 11 | IPR011989 |
| Domain | 7TM_GPCR_Srsx | 3.26e-04 | 112 | 216 | 7 | SM01381 | |
| Domain | LPA_rcpt | 3.96e-04 | 3 | 216 | 2 | IPR004065 | |
| Domain | SAPS | 3.96e-04 | 3 | 216 | 2 | IPR007587 | |
| Domain | SAPS | 3.96e-04 | 3 | 216 | 2 | PF04499 | |
| Domain | AA_permease_2 | 4.00e-04 | 13 | 216 | 3 | PF13520 | |
| Domain | AA/rel_permease1 | 4.00e-04 | 13 | 216 | 3 | IPR002293 | |
| Domain | SEA | 5.05e-04 | 14 | 216 | 3 | SM00200 | |
| Domain | GPCR_2_extracellular_dom | 1.15e-03 | 40 | 216 | 4 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 1.15e-03 | 40 | 216 | 4 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 1.15e-03 | 40 | 216 | 4 | PS50227 | |
| Domain | - | 1.15e-03 | 222 | 216 | 9 | 1.25.10.10 | |
| Domain | Nuc_sug_transp | 1.30e-03 | 5 | 216 | 2 | PF04142 | |
| Domain | Nuc_sug_transpt | 1.30e-03 | 5 | 216 | 2 | IPR007271 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR7E24 OR4F4 OR4D2 OR2K2 OR4F5 OR6C76 OR6C1 OR6C75 OR6J1 OR4F17 OR2H2 OR5P2 OR8J2 OR4N5 OR6S1 OR6C74 OR10X1 OR52J3 OR6C2 OR6C4 OR4C12 OR4B1 OR4K5 OR4F15 | 1.04e-10 | 417 | 165 | 24 | M4072 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR7E24 OR4F4 OR4D2 OR2K2 OR4F5 OR6C76 OR6C1 OR6C75 OR4F17 OR2H2 OR5P2 OR4N5 OR6S1 OR6C74 OR10X1 OR52J3 OR6C2 OR6C4 OR4C12 OR4B1 OR4K5 OR4F15 | 9.33e-10 | 389 | 165 | 22 | M14091 |
| Pathway | WP_GPCRS_NONODORANT | LPAR3 MC1R MC2R CHRM1 PTH1R FFAR4 TAS2R4 CNR1 VIPR1 NPY6R HTR1D HTR2B GRM7 CCKBR LPAR2 RXFP1 ACKR1 GABBR1 | 2.13e-09 | 266 | 165 | 18 | MM15843 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR7E24 OR4F4 OR4D2 OR2K2 OR4F5 TAS2R4 OTOGL OR6C76 OR6C1 OR6C75 OR6J1 OR4F17 OR2H2 OR5P2 OR8J2 OR4N5 OR6S1 OR6C74 APOB OR10X1 OR52J3 OR6C2 OR6C4 OR4C12 OR4B1 OR4K5 OR4F15 | 5.45e-09 | 636 | 165 | 27 | M41834 |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | LPAR3 MC1R MC2R CHRM1 PTH1R CHRNB3 CNR1 VIPR1 HTR1D HTR2B GRM7 CCKBR LPAR2 RXFP1 GABBR1 | 7.11e-07 | 272 | 165 | 15 | M13380 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC36A1 ADCY1 ABCA10 SLC39A8 SLC13A4 PSME4 AP2A2 ATP2C2 SLC35A2 ATP11C SLC5A10 ABCC5 APOB SLC34A3 CUBN SLC7A6 AQP1 MCOLN1 SLC9C2 SLC1A2 SLC1A6 SLC7A1 SLC35A3 ATP2C1 SLC12A3 | 1.46e-06 | 736 | 165 | 25 | M27287 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | MC1R MC2R CHRM1 OR10D4P CNR1 NPY6R HTR1D HTR2B GPR33 CCKBR GABBR1 | 1.18e-05 | 186 | 165 | 11 | MM15994 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC36A1 SLC39A8 SLC13A4 SLC35A2 SLC5A10 SLC34A3 SLC7A6 SLC1A2 SLC1A6 SLC7A1 SLC35A3 SLC12A3 | 2.35e-05 | 238 | 165 | 12 | MM15076 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | LPAR3 MC1R MC2R CHRM1 PTH1R FFAR4 TAS2R4 CNR1 VIPR1 HTR1D HTR2B GRM7 CCKBR LPAR2 RXFP1 ACKR1 GABBR1 | 3.05e-05 | 463 | 165 | 17 | M507 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC36A1 SLC39A8 SLC13A4 SLC35A2 SLC5A10 SLC34A3 SLC7A6 SLC1A2 SLC1A6 SLC7A1 SLC35A3 SLC12A3 | 3.67e-05 | 249 | 165 | 12 | M5988 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC36A1 SLC39A8 SLC13A4 PSME4 AP2A2 ATP2C2 SLC35A2 ATP11C SLC5A10 ABCC5 APOB SLC34A3 SLC7A6 AQP1 MCOLN1 SLC1A2 SLC1A6 SLC7A1 SLC35A3 ATP2C1 SLC12A3 | 4.62e-05 | 681 | 165 | 21 | MM14985 |
| Pathway | BIOCARTA_CHREBP_PATHWAY | 6.12e-05 | 19 | 165 | 4 | M22004 | |
| Pathway | WP_GPCRS_OTHER | 1.08e-04 | 93 | 165 | 7 | M39629 | |
| Pathway | BIOCARTA_AKAP13_PATHWAY | 1.26e-04 | 9 | 165 | 3 | MM1477 | |
| Pathway | WP_GPCRS_OTHER | 1.32e-04 | 96 | 165 | 7 | MM15939 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | LPAR3 MC1R MC2R CHRM1 PTH1R TAS2R4 CNR1 VIPR1 HTR1D HTR2B GRM7 CCKBR LPAR2 RXFP1 GABBR1 | 1.61e-04 | 430 | 165 | 15 | MM15160 |
| Pathway | BIOCARTA_AKAP13_PATHWAY | 2.42e-04 | 11 | 165 | 3 | M17668 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 2.74e-04 | 108 | 165 | 7 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 2.90e-04 | 109 | 165 | 7 | MM15074 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | LPAR3 MC1R MC2R CHRM1 FFAR4 CNR1 HTR1D HTR2B CCKBR LPAR2 RXFP1 ACKR1 | 5.10e-04 | 330 | 165 | 12 | M18334 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | LPAR3 MC1R MC2R CHRM1 PLEKHG5 ADCY1 PTH1R FFAR4 TAS2R4 CNR1 VIPR1 HTR1D HTR2B GRM7 CCKBR LPAR2 RXFP1 ACKR1 GABBR1 | 5.65e-04 | 702 | 165 | 19 | M746 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | LPAR3 MC1R MC2R CHRM1 PLEKHG5 ADCY1 PTH1R FFAR4 TAS2R4 CNR1 VIPR1 HTR1D HTR2B GRM7 CCKBR LPAR2 RXFP1 GABBR1 | 5.66e-04 | 646 | 165 | 18 | MM14962 |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR7E24 OR4F4 OR4D2 OR10D4P OR2K2 OR6C76 OR6C1 OR6C75 OR2H2 OR5P2 OR4N5 OR6S1 OR6C74 OR10X1 OR52J3 OR6C2 OR4C12 OR4B1 OR4K5 OR4F15 | 1.04e-13 | 340 | 224 | 20 | 11875048 |
| Pubmed | OR7E24 OR4F4 OR4D2 OR10D4P OR2K2 OR6C76 OR6C1 OR6C75 OR2H2 OR5P2 OR4N5 OR6S1 OR6C74 OR10X1 OR52J3 OR6C2 OR4C12 OR4B1 OR4K5 OR4F15 | 1.22e-13 | 343 | 224 | 20 | 32295537 | |
| Pubmed | OR7E24 OR4F4 OR4D2 OR10D4P OR2K2 OR6C76 OR6C1 OR6C75 OR2H2 OR5P2 OR4N5 OR6S1 OR6C74 OR10X1 OR52J3 OR6C2 OR4C12 OR4B1 OR4K5 OR4F15 | 1.44e-13 | 346 | 224 | 20 | 14611657 | |
| Pubmed | OR7E24 OR4F4 OR4D2 OR10D4P OR2K2 OR6C76 OR6C1 OR6C75 OR2H2 OR5P2 OR4N5 OR6C74 OR10X1 OR52J3 OR6C2 OR4C12 OR4B1 OR4K5 OR4F15 | 1.09e-12 | 340 | 224 | 19 | 11802173 | |
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 5.34e-09 | 118 | 224 | 10 | 19156168 | |
| Pubmed | 8.15e-09 | 24 | 224 | 6 | 24152035 | ||
| Pubmed | OR7E24 OR4F4 OR4D2 OR10D4P OR2K2 OR2H2 OR5P2 OR4N5 OR6S1 OR6C74 OR10X1 OR52J3 OR6C4 OR4C12 OR4B1 OR4K5 OR4F15 | 1.00e-07 | 541 | 224 | 17 | 14983052 | |
| Pubmed | RELN CHRM1 CHRNB3 CNR1 VIPR1 HTR1D HTR2B GRM7 SLC1A2 SLC1A6 CCKBR GABBR1 | 6.62e-07 | 300 | 224 | 12 | 19086053 | |
| Pubmed | Integration of neuronal clones in the radial cortical columns by EphA and ephrin-A signalling. | 2.16e-06 | 15 | 224 | 4 | 19759535 | |
| Pubmed | 3.73e-06 | 17 | 224 | 4 | 16472605 | ||
| Pubmed | 5.20e-06 | 6 | 224 | 3 | 25582271 | ||
| Pubmed | SLC7A13 SLC39A8 NPHS1 REN SLC7A6 SLC35A3 SLC12A3 SLC4A11 SLC35B1 | 1.05e-05 | 212 | 224 | 9 | 19521566 | |
| Pubmed | Activation of Hypoxia Signaling in Stromal Progenitors Impairs Kidney Development. | 1.30e-05 | 47 | 224 | 5 | 28527294 | |
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | 1.36e-05 | 219 | 224 | 9 | 12213199 | |
| Pubmed | ABO, Rh, MNS, Duffy, Kidd,Yt, Scianna, and Colton blood group systems in indigenous Chinese. | 1.44e-05 | 8 | 224 | 3 | 15783300 | |
| Pubmed | 3.04e-05 | 28 | 224 | 4 | 28847650 | ||
| Pubmed | Secretory pathway Ca2+ -ATPases promote in vitro microcalcifications in breast cancer cells. | 4.13e-05 | 2 | 224 | 2 | 28618103 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 16194893 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 36925204 | ||
| Pubmed | 5-HT1D and 5-HT2B receptors mediate contraction of smooth muscle in human small intestine. | 4.13e-05 | 2 | 224 | 2 | 9186750 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 25531720 | ||
| Pubmed | NuMA is required for the selective induction of p53 target genes. | 4.13e-05 | 2 | 224 | 2 | 23589328 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 27810909 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 23687433 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 16332677 | ||
| Pubmed | Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells. | 4.13e-05 | 2 | 224 | 2 | 19001604 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 11689484 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 11689483 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 33347862 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 25463482 | ||
| Pubmed | Glucose-dependent transcriptional regulation by an evolutionarily conserved glucose-sensing module. | 4.13e-05 | 2 | 224 | 2 | 16644671 | |
| Pubmed | Upregulation of KIF11 in TP53 Mutant Glioma Promotes Tumor Stemness and Drug Resistance. | 4.13e-05 | 2 | 224 | 2 | 33491154 | |
| Pubmed | Lysophosphatidic acid receptors 2 and 3 regulate erythropoiesis at different hematopoietic stages. | 4.13e-05 | 2 | 224 | 2 | 33035680 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 26910886 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 23925696 | ||
| Pubmed | Diagnostic value of serum CA125, CA19-9 and CA15-3 in endometriosis: A meta-analysis. | 4.13e-05 | 2 | 224 | 2 | 26246541 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 20123976 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 28981686 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 25176168 | ||
| Pubmed | Comparison of the transmembrane mucins MUC1 and MUC16 in epithelial barrier function. | 4.13e-05 | 2 | 224 | 2 | 24968021 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 18510673 | ||
| Pubmed | p53 directly represses Id2 to inhibit the proliferation of neural progenitor cells. | 4.13e-05 | 2 | 224 | 2 | 21608079 | |
| Pubmed | MRP5 and MRP9 play a concerted role in male reproduction and mitochondrial function. | 4.13e-05 | 2 | 224 | 2 | 35121660 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 32006610 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 30011875 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 23583405 | ||
| Pubmed | ChIP-on-chip analysis of in vivo mutant p53 binding to selected gene promoters. | 4.13e-05 | 2 | 224 | 2 | 21332394 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 20598042 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 27003157 | ||
| Pubmed | MondoA Is an Essential Glucose-Responsive Transcription Factor in Human Pancreatic β-Cells. | 4.13e-05 | 2 | 224 | 2 | 29282201 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 24039759 | ||
| Pubmed | The cloning of a family of genes that encode the melanocortin receptors. | 4.13e-05 | 2 | 224 | 2 | 1325670 | |
| Pubmed | Nipple discharge of CA15-3, CA125, CEA and TSGF as a new biomarker panel for breast cancer. | 4.13e-05 | 2 | 224 | 2 | 24879526 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 22622028 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 23635510 | ||
| Pubmed | Polymorphisms of MUC16 (CA125) and MUC1 (CA15.3) in relation to ovarian cancer risk and survival. | 4.13e-05 | 2 | 224 | 2 | 24551091 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 33406026 | ||
| Pubmed | Different Levels of CEA, CA153 and CA125 in Milk and Benign and Malignant Nipple Discharge. | 4.13e-05 | 2 | 224 | 2 | 27327081 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 18665841 | ||
| Pubmed | Pharmacological activation of lysophosphatidic acid receptors regulates erythropoiesis. | 4.13e-05 | 2 | 224 | 2 | 27244685 | |
| Pubmed | Muscarinic M1 receptor and cannabinoid CB1 receptor do not modulate paraoxon-induced seizures. | 4.13e-05 | 2 | 224 | 2 | 25692018 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 18460195 | ||
| Pubmed | Renin, a secretory glycoprotein, acquires phosphomannosyl residues. | 4.13e-05 | 2 | 224 | 2 | 2960682 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 23368718 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 24022481 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 17101792 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 25454345 | ||
| Pubmed | Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer. | 4.13e-05 | 2 | 224 | 2 | 28637689 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 33462738 | ||
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 23089177 | ||
| Pubmed | 5.23e-05 | 32 | 224 | 4 | 19571125 | ||
| Pubmed | 5.56e-05 | 12 | 224 | 3 | 22228756 | ||
| Pubmed | 5.56e-05 | 12 | 224 | 3 | 37143315 | ||
| Pubmed | 7.19e-05 | 13 | 224 | 3 | 38692273 | ||
| Pubmed | Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. | 7.40e-05 | 67 | 224 | 5 | 21875946 | |
| Pubmed | 8.39e-05 | 36 | 224 | 4 | 33737325 | ||
| Pubmed | 9.11e-05 | 14 | 224 | 3 | 34550336 | ||
| Pubmed | 9.12e-05 | 70 | 224 | 5 | 12036966 | ||
| Pubmed | NCOA3 ZGRF1 TOX4 SALL1 SYNJ1 GCN1 KIF11 PPP6R1 TBK1 CUX1 EXOC4 | 9.40e-05 | 418 | 224 | 11 | 34709266 | |
| Pubmed | 1.15e-04 | 39 | 224 | 4 | 21347282 | ||
| Pubmed | Odorant and vomeronasal receptor genes in two mouse genome assemblies. | 1.19e-04 | 74 | 224 | 5 | 15081110 | |
| Pubmed | High-throughput analyses of hnRNP H1 dissects its multi-functional aspect. | SP3 EMC7 ADAM15 SRF PSME4 SLC12A9 TRMT1L RNF145 ZYG11A TNPO2 SLC7A6 CEP164 MLXIPL SLC12A3 CD37 B4GALNT2 GABBR1 EXOC4 | 1.22e-04 | 1021 | 224 | 18 | 26760575 |
| Pubmed | 1.23e-04 | 3 | 224 | 2 | 23053434 | ||
| Pubmed | Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinoma. | 1.23e-04 | 3 | 224 | 2 | 12893366 | |
| Pubmed | Involvement of p53 in alpha4beta1 integrin-mediated resistance of B-CLL cells to fludarabine. | 1.23e-04 | 3 | 224 | 2 | 14623330 | |
| Pubmed | 1.23e-04 | 3 | 224 | 2 | 11897010 | ||
| Pubmed | Two novel CNRs from the CNR gene cluster have molecular features distinct from those of CNR1 to 8. | 1.23e-04 | 3 | 224 | 2 | 11401448 | |
| Pubmed | 1.23e-04 | 3 | 224 | 2 | 27070462 | ||
| Pubmed | A cluster of proton/amino acid transporter genes in the human and mouse genomes. | 1.23e-04 | 3 | 224 | 2 | 12809675 | |
| Pubmed | Enhancement of invasion of hepatocellular carcinoma cells through lysophosphatidic acid receptor. | 1.23e-04 | 3 | 224 | 2 | 23569130 | |
| Pubmed | 1.23e-04 | 3 | 224 | 2 | 8463333 | ||
| Pubmed | 1.23e-04 | 3 | 224 | 2 | 18973587 | ||
| Pubmed | 1.23e-04 | 3 | 224 | 2 | 19899077 | ||
| Pubmed | Lysophosphatidic acid receptor 2/3-mediated IL-8-dependent angiogenesis in cervical cancer cells. | 1.23e-04 | 3 | 224 | 2 | 21964883 | |
| Pubmed | 1.23e-04 | 3 | 224 | 2 | 24939955 | ||
| Pubmed | 1.23e-04 | 3 | 224 | 2 | 19025891 | ||
| Pubmed | Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine. | 1.23e-04 | 3 | 224 | 2 | 10097137 | |
| Pubmed | 1.23e-04 | 3 | 224 | 2 | 22833670 | ||
| Pubmed | Reelin signaling modulates GABAB receptor function in the neocortex. | 1.23e-04 | 3 | 224 | 2 | 32083308 | |
| Pubmed | 1.23e-04 | 3 | 224 | 2 | 30185628 | ||
| Cytoband | 12q13.2 | 1.03e-08 | 55 | 225 | 7 | 12q13.2 | |
| GeneFamily | Solute carriers | SLC46A2 SLC36A1 SLC7A13 SLC39A8 SLC13A4 SLC12A9 SLC22A14 SLC35A2 SLC5A10 SLC34A3 SLC7A6 SLC9C2 SLC1A2 SLC1A6 SLC35F5 SLC7A1 SLC35A3 SLC12A3 SLC36A3 SLC4A11 SLC35B1 SLC22A31 | 2.72e-11 | 395 | 172 | 22 | 752 |
| GeneFamily | Olfactory receptors, family 6 | 2.56e-08 | 51 | 172 | 8 | 153 | |
| GeneFamily | Olfactory receptors, family 4 | 3.99e-06 | 129 | 172 | 9 | 151 | |
| GeneFamily | ZYG11 cell cycle regulator family | 2.68e-04 | 3 | 172 | 2 | 6 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 4.09e-04 | 37 | 172 | 4 | 454 | |
| GeneFamily | Melanocortin receptors | 8.83e-04 | 5 | 172 | 2 | 236 | |
| GeneFamily | CD molecules|Mucins | 9.92e-04 | 21 | 172 | 3 | 648 | |
| GeneFamily | Protein phosphatase 6 regulatory subunits | 1.32e-03 | 6 | 172 | 2 | 699 | |
| GeneFamily | Lysophosphatidic acid receptors | 1.32e-03 | 6 | 172 | 2 | 205 | |
| GeneFamily | Zinc fingers GRF-type|Topoisomerases | 1.83e-03 | 7 | 172 | 2 | 135 | |
| GeneFamily | CUT class homeoboxes and pseudogenes | 3.10e-03 | 9 | 172 | 2 | 527 | |
| GeneFamily | ATPases Ca2+ transporting | 3.10e-03 | 9 | 172 | 2 | 1209 | |
| GeneFamily | VPS9 domain containing | 3.85e-03 | 10 | 172 | 2 | 928 | |
| GeneFamily | CD molecules|C-type lectin domain family|Killer cell lectin like receptors | 5.58e-03 | 12 | 172 | 2 | 621 | |
| GeneFamily | ATP binding cassette subfamily C | 6.55e-03 | 13 | 172 | 2 | 807 | |
| GeneFamily | 5-hydroxytryptamine receptors, G protein-coupled | 6.55e-03 | 13 | 172 | 2 | 170 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_A | OR4F4 MFF OR10D4P GCN1 NIPBL OR5P2 OR6C2 OR4C12 OR4K5 OR4F15 | 5.60e-06 | 194 | 218 | 10 | M2517 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.66e-06 | 151 | 199 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k2 | |
| CoexpressionAtlas | kidney | SLC7A13 PTH1R OTOGL UGT2A1 PKLR PKHD1 ADGRF1 NPHS1 SLC5A10 REN SLC34A3 CUBN SLC12A3 | 1.20e-05 | 323 | 199 | 13 | kidney |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#1_top-relative-expression-ranked_500 | 3.00e-05 | 64 | 199 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_200 | 4.79e-05 | 178 | 199 | 9 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_100 | 6.53e-05 | 9 | 199 | 3 | gudmap_developingKidney_e15.5_Cap mesenchyme_100_k5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | SLC7A13 DSCAML1 PTH1R FAT3 CUBN GRM7 MLXIPL SLC12A3 LINGO1 TMEM132D CSMD1 CUX1 | 1.19e-10 | 181 | 220 | 12 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | DCHS2 SLC7A13 ADGRV1 SLC22A14 UGT2A1 SLC5A10 LBP CUBN AQP1 MLXIPL CSMD1 | 2.03e-09 | 183 | 220 | 11 | d73cac83cde82665f110baad7cf28db75f9ffe52 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN ADGRV1 PKD1L2 CHRM1 DSCAML1 OTOGL PKHD1 FAT3 APOB HMCN1 CSMD1 | 2.15e-09 | 184 | 220 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN ADGRV1 PKD1L2 CHRM1 DSCAML1 OTOGL PKHD1 FAT3 APOB HMCN1 CSMD1 | 2.15e-09 | 184 | 220 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RELN ADGRV1 PKD1L2 CHRM1 DSCAML1 OTOGL PKHD1 FAT3 APOB HMCN1 CSMD1 | 2.15e-09 | 184 | 220 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | ADGRV1 ADCY1 OTOGL CD177 FAT3 MUC16 PRKAG3 HMCN1 ABCC12 CSMD1 | 5.02e-08 | 195 | 220 | 10 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | ADGRV1 ADCY1 OTOGL CD177 FAT3 MUC16 PRKAG3 HMCN1 ABCC12 CSMD1 | 5.02e-08 | 195 | 220 | 10 | d3755929ebbbf5e3afde44281e9056ddb614a291 |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.22e-07 | 182 | 220 | 9 | 4a9c13932e7163fd37a3dcc4c6ca3bbea5372459 | |
| ToppCell | PCW_07-8.5-Hematologic_ErythroMegGranulo|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.87e-07 | 186 | 220 | 9 | 294839944266407c40ef86e1d3e0fce4652b70ff | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-erythro|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.24e-07 | 188 | 220 | 9 | 29d804232d974a8c0029300345b287005b09bade | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_ErythroMeg|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.24e-07 | 188 | 220 | 9 | 5d6faf45a9c0794b0c30b0a0601c10afbb8aa9ed | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.24e-07 | 188 | 220 | 9 | a0873783f0a2cd852563c05a275dddc72905ced2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | CHRM1 ATP2C2 GRM7 SLC1A2 PCDH20 TMEM132D LRRTM2 CSMD1 KIF13A | 6.82e-07 | 199 | 220 | 9 | 19a97e27a4758e794ce7246d295e112b47931a48 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | CHRM1 ATP2C2 GRM7 SLC1A2 PCDH20 TMEM132D LRRTM2 CSMD1 GABBR1 | 6.82e-07 | 199 | 220 | 9 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | CHRM1 ATP2C2 GRM7 SLC1A2 PCDH20 TMEM132D LRRTM2 CSMD1 GABBR1 | 6.82e-07 | 199 | 220 | 9 | 333056c2abe9724efeab542c0365fcfe4eff8f18 |
| ToppCell | droplet-Liver-Npc-21m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-06 | 157 | 220 | 8 | 264b22d0ffc43049161843bb55d2eccbf5fca575 | |
| ToppCell | droplet-Liver-Npc-21m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-06 | 157 | 220 | 8 | 67945d37027be62c880d3072afa7ca7e97c76c20 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.14e-06 | 170 | 220 | 8 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Primitive_erythrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.77e-06 | 176 | 220 | 8 | 664a7d15563428d0ae156d97aa88415fd0a0506a | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell-4|TCGA-Uvea / Sample_Type by Project: Shred V9 | 3.84e-06 | 184 | 220 | 8 | 9c56753e5e668be888662e4713cf4ce44e6c58fb | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.00e-06 | 185 | 220 | 8 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | PCW_07-8.5-Hematologic_ErythroMegGranulo-Hem_ErythroMeg|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.16e-06 | 186 | 220 | 8 | 3b60a153e6cfc1b977a1f8b8f3bcaf75d1f4ff5b | |
| ToppCell | PCW_07-8.5-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-erythro|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.16e-06 | 186 | 220 | 8 | 6078aa16261554c7fd41137b8de1362d15b30490 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Cycling_definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.33e-06 | 187 | 220 | 8 | c0965293f08d3e49000871777a5b26d81a4af203 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.51e-06 | 188 | 220 | 8 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.51e-06 | 188 | 220 | 8 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.87e-06 | 190 | 220 | 8 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.47e-06 | 193 | 220 | 8 | 8646e573f2d2ff175f3d02bfdf214e65f3b614d3 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.84e-06 | 199 | 220 | 8 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.10e-06 | 200 | 220 | 8 | ad777683adeb2ce45ade570386235e311fa7ea2d | |
| ToppCell | LPS-antiTNF-Endothelial-Epi-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.57e-06 | 144 | 220 | 7 | 75b16adfbe84f69376e6566d531ba7919d5c5192 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.46e-06 | 149 | 220 | 7 | 48fca6ae33d7722c024b43ce04f4dbce7b6b424b | |
| ToppCell | LPS-antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.89e-06 | 150 | 220 | 7 | 9cb3332924bd67c966873343c14445e30d3f384f | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 152 | 220 | 7 | 7e686721b95c837f2b0d5116927c8ecacef055ee | |
| ToppCell | Posterior_cortex|World / BrainAtlas - Mouse McCarroll V32 | 1.44e-05 | 159 | 220 | 7 | 18e9fe2efbe0bca7c3990f3b12b6f549e2c1263a | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 160 | 220 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 160 | 220 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 11.5-Distal-RBC|Distal / Age, Tissue, Lineage and Cell class | 1.70e-05 | 163 | 220 | 7 | e9d814952d824539ff1dea119e4fca14a8c335a8 | |
| ToppCell | 11.5-Distal-RBC-RBC|Distal / Age, Tissue, Lineage and Cell class | 1.70e-05 | 163 | 220 | 7 | 31b60e065bac4ad380247964e7574f210106ebae | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-05 | 164 | 220 | 7 | a67dd181eba275c191f4d0cab13df30eaa3ad913 | |
| ToppCell | Frontal_cortex|World / BrainAtlas - Mouse McCarroll V32 | 1.76e-05 | 164 | 220 | 7 | e09291711abf8680e78170328313719092b0142f | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.14e-05 | 169 | 220 | 7 | 04c6ed38e1d1befba5ef5f37a3c1e045a0b163d6 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.14e-05 | 169 | 220 | 7 | 58136b8a0bf2dab45c91a053ef7225ea49ccb871 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 2.22e-05 | 170 | 220 | 7 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.40e-05 | 172 | 220 | 7 | 3a76cfb2832790144a6da6406469ead0767916b5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-05 | 175 | 220 | 7 | 2f43883d7c89f09b0579a390a7431f1f9b832582 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-05 | 175 | 220 | 7 | da92eb8af0c7c65fed4a1d960708240f35dd997d | |
| ToppCell | (03)_Secretory|World / shred by cell type and Timepoint | 2.78e-05 | 176 | 220 | 7 | cb7b1945788196ca79007f0768b6576ec885a0e5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.99e-05 | 178 | 220 | 7 | 0e1bedf991189d0ef9b40dac9281bdf4739333a1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.09e-05 | 179 | 220 | 7 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.09e-05 | 179 | 220 | 7 | bf012825e88626e59cd1deebf67c2cd269ce4829 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-05 | 180 | 220 | 7 | 6ac62bf1251978c8c12e715f7b73144fca619794 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.32e-05 | 181 | 220 | 7 | f4cd6dba4c04c5cb550f44468eb29c07238fbda4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-05 | 181 | 220 | 7 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Red_blood_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.32e-05 | 181 | 220 | 7 | c7f5d0e5aa2ca6a409957713637e1b37a73ceb60 | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Definitive_erythroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.44e-05 | 182 | 220 | 7 | 0c77ef4556c1d1512ebe9077df858b28f9e38dd5 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-macrophage|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-05 | 182 | 220 | 7 | df26388c0c46d1c4775103c8e802937b4d4e7470 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.44e-05 | 182 | 220 | 7 | 1adb8d6404d50155e9f9ba805abef63929fe865f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.44e-05 | 182 | 220 | 7 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-leukocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-05 | 183 | 220 | 7 | 062ec08d66c923f90fee771b1bf8d98bdc7e6c1b | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.56e-05 | 183 | 220 | 7 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.56e-05 | 183 | 220 | 7 | 7eecb8d80e31ca26c2e6ce43bf0f2c71be1643e4 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-05 | 183 | 220 | 7 | 919c9861073d12fd12aecd7469b1478b13838c43 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.69e-05 | 184 | 220 | 7 | 0efc757d9512d6a8fe8176e977a94e4494ed9778 | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.69e-05 | 184 | 220 | 7 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-erythro|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.95e-05 | 186 | 220 | 7 | 34ed60e846fd83fab3e28dc9e278bcc4b092a9f0 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.95e-05 | 186 | 220 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 4.09e-05 | 187 | 220 | 7 | 738ec2611b4be6a08eedad16b57fba84e1f11fef | |
| ToppCell | AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 4.37e-05 | 189 | 220 | 7 | 2d32f09efa982ae458568f6b1cd06bb5078d42a3 | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|kidney / Disease (COVID-19 only), tissue and cell type | 4.40e-05 | 129 | 220 | 6 | 57b705106aec7bbfc587de1ccd4f2335fc44dd6f | |
| ToppCell | 368C-Epithelial_cells|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.52e-05 | 190 | 220 | 7 | 459811e88d3001816c2d89034e0921c24918c17f | |
| ToppCell | P15-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.52e-05 | 190 | 220 | 7 | d072bb285bd34d518b958e7c9ad44739c60b359c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.52e-05 | 190 | 220 | 7 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.67e-05 | 191 | 220 | 7 | 6cb2c107bc674aa173b4009f320a1687a76f3979 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-05 | 191 | 220 | 7 | 318323a12029a7992f16382cb0c186f5b2e1ca47 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.67e-05 | 191 | 220 | 7 | 4aa29337f4d2528577bb90dc4abfb6eab93e120f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 4.83e-05 | 192 | 220 | 7 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.83e-05 | 192 | 220 | 7 | 3e1a4cb0d83efd502c8613d41a1692bdda5860ed | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.83e-05 | 192 | 220 | 7 | b73f24d1c55dfef1eb01c26da117dbf637ea080a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.99e-05 | 193 | 220 | 7 | ffa1932da2979d7b63dbac32eb5788346a3f5b2a | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-05 | 193 | 220 | 7 | a6a864644e1b80b7417ea0a27281e79068a3fd3d | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Mucinous_Adenocarcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 5.01e-05 | 132 | 220 | 6 | 6480feb3e4e898d610615ce14f598f419c623e07 | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.16e-05 | 194 | 220 | 7 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.16e-05 | 194 | 220 | 7 | 46266d3d9af7000dc1381b1c8e55047193cbcf94 | |
| ToppCell | normal_Lung-Epithelial_cells-AT2|Epithelial_cells / Location, Cell class and cell subclass | 5.33e-05 | 195 | 220 | 7 | 81e13fe337f1d0a83d0deb86a0df797d306cd24d | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.33e-05 | 195 | 220 | 7 | d67a2b489c29bfd575751c13d2a5b1efdec5240a | |
| ToppCell | control-Myeloid-CD16_Monocytes|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.33e-05 | 195 | 220 | 7 | f398d08a23fdfa6202f73a7aeac3ff4c997fbdfd | |
| ToppCell | severe-B_intermediate|severe / disease stage, cell group and cell class | 5.50e-05 | 196 | 220 | 7 | 8f59e51ca50bef4753f67cd1efdb02665805a120 | |
| ToppCell | Skin-Tubules|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 5.50e-05 | 196 | 220 | 7 | 12e21cc310a261407b46e034108e8c93ea16e045 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.50e-05 | 196 | 220 | 7 | b1abecc0aafc09ca70a5fde624f2a998c4aa3341 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-NK-ILC-T_NK-ILC|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.68e-05 | 197 | 220 | 7 | 9791923feefbd78810242113ad2a08ce4c2bb4f2 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.68e-05 | 197 | 220 | 7 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.68e-05 | 197 | 220 | 7 | c6645db1bfb5a352cfbb8d83fd1929dcfd41e216 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.87e-05 | 198 | 220 | 7 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.87e-05 | 198 | 220 | 7 | 33690e16e4549b110e5b67f84b9515c696fe05e1 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.87e-05 | 198 | 220 | 7 | d02e1ff7f68dedaca1e367c7cade772e7b355f45 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.05e-05 | 199 | 220 | 7 | 598937913fe1f12d741fa49e23ae195a7be5cbe3 | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 6.05e-05 | 199 | 220 | 7 | 9a65acfe9bf500db72142469cf17bf0973540001 | |
| ToppCell | Sigmoid-NK_cell-NK|Sigmoid / Region, Cell class and subclass | 6.05e-05 | 199 | 220 | 7 | 5aa943ef7a1764ce4e95a7163aaabe2ee89eb870 | |
| ToppCell | Sigmoid-NK_cell|Sigmoid / Region, Cell class and subclass | 6.05e-05 | 199 | 220 | 7 | 653965a8bb09abcab7d275b01d361b7b4e3fdd58 | |
| Computational | Genes in the cancer module 146. | 9.55e-05 | 102 | 113 | 7 | MODULE_146 | |
| Disease | Colorectal Carcinoma | DSCAML1 ABCA10 MFF PKHD1 PAN2 ATP11C ABCC5 APOB CUBN CBFA2T3 SIGLEC7 B4GALNT2 CUX1 TP53 HDC EXOC4 | 3.98e-05 | 702 | 207 | 16 | C0009402 |
| Disease | Depressive disorder | 4.08e-05 | 289 | 207 | 10 | C0011581 | |
| Disease | 1,5 anhydroglucitol measurement | 4.87e-05 | 29 | 207 | 4 | EFO_0008009 | |
| Disease | level of Diacylglycerol (18:1_18:1) in blood serum | 5.39e-05 | 11 | 207 | 3 | OBA_2045170 | |
| Disease | Amyotrophic Lateral Sclerosis | 5.48e-05 | 58 | 207 | 5 | C0002736 | |
| Disease | resting heart rate, chronic obstructive pulmonary disease | 5.59e-05 | 30 | 207 | 4 | EFO_0000341, EFO_0004351 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 6.46e-05 | 60 | 207 | 5 | EFO_0022237 | |
| Disease | Mental Depression | 8.28e-05 | 254 | 207 | 9 | C0011570 | |
| Disease | lethal congenital glycogen storage disease of heart (implicated_via_orthology) | 1.46e-04 | 3 | 207 | 2 | DOID:0090101 (implicated_via_orthology) | |
| Disease | triglycerides to total lipids in small HDL percentage | 1.55e-04 | 72 | 207 | 5 | EFO_0022336 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.30e-04 | 291 | 207 | 9 | EFO_0008317, EFO_0020946 | |
| Disease | melanoma | 2.71e-04 | 126 | 207 | 6 | EFO_0000756 | |
| Disease | familial juvenile hyperuricemic nephropathy (is_implicated_in) | 2.91e-04 | 4 | 207 | 2 | DOID:0060062 (is_implicated_in) | |
| Disease | Wolff-Parkinson-White syndrome (implicated_via_orthology) | 2.91e-04 | 4 | 207 | 2 | DOID:384 (implicated_via_orthology) | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 4.21e-04 | 50 | 207 | 4 | EFO_0022247 | |
| Disease | Cocaine Dependence | 4.59e-04 | 139 | 207 | 6 | C0600427 | |
| Disease | Choledochal Cyst, Type I | 4.83e-04 | 5 | 207 | 2 | C0009439 | |
| Disease | Choledochal Cyst, Type II | 4.83e-04 | 5 | 207 | 2 | C1257796 | |
| Disease | Choledochal Cyst, Type III | 4.83e-04 | 5 | 207 | 2 | C1257797 | |
| Disease | Choledochal Cyst, Type IV | 4.83e-04 | 5 | 207 | 2 | C1257798 | |
| Disease | Choledochal Cyst, Type V | 4.83e-04 | 5 | 207 | 2 | C1257799 | |
| Disease | Choledochal Cyst | 4.83e-04 | 5 | 207 | 2 | C0008340 | |
| Disease | Renal glomerular disease | 5.43e-04 | 23 | 207 | 3 | C0268731 | |
| Disease | Glomerulopathy Assessment | 5.43e-04 | 23 | 207 | 3 | C4521256 | |
| Disease | Small cell carcinoma of lung | 5.65e-04 | 54 | 207 | 4 | C0149925 | |
| Disease | Alcoholic Intoxication, Chronic | 6.44e-04 | 268 | 207 | 8 | C0001973 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 6.57e-04 | 206 | 207 | 7 | EFO_0004612, EFO_0020947 | |
| Disease | toxic shock syndrome (biomarker_via_orthology) | 7.21e-04 | 6 | 207 | 2 | DOID:14115 (biomarker_via_orthology) | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 7.21e-04 | 6 | 207 | 2 | DOID:0050429 (implicated_via_orthology) | |
| Disease | Obsessive-Compulsive Disorder | 7.21e-04 | 6 | 207 | 2 | C0028768 | |
| Disease | Withdrawal Symptoms | 7.42e-04 | 58 | 207 | 4 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 7.42e-04 | 58 | 207 | 4 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 7.42e-04 | 58 | 207 | 4 | C0038587 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 8.12e-04 | 103 | 207 | 5 | EFO_0008595, EFO_0020944 | |
| Disease | cholesterol to total lipids in IDL percentage | 8.44e-04 | 60 | 207 | 4 | EFO_0022233 | |
| Disease | triglycerides to total lipids in IDL percentage | 1.01e-03 | 63 | 207 | 4 | EFO_0022329 | |
| Disease | Amyotrophic Lateral Sclerosis With Dementia | 1.09e-03 | 29 | 207 | 3 | C0393554 | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.09e-03 | 110 | 207 | 5 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | Marijuana Abuse | 1.20e-03 | 30 | 207 | 3 | C0024809 | |
| Disease | total lipids in very large HDL measurement | 1.21e-03 | 66 | 207 | 4 | EFO_0022312 | |
| Disease | phospholipids in very large HDL measurement | 1.21e-03 | 66 | 207 | 4 | EFO_0022298 | |
| Disease | common carotid intimal medial thickness | 1.28e-03 | 67 | 207 | 4 | EFO_0004860 | |
| Disease | Amyotrophic Lateral Sclerosis, Guam Form | 1.32e-03 | 31 | 207 | 3 | C0543859 | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 1.32e-03 | 31 | 207 | 3 | EFO_0022249 | |
| Disease | stachydrine measurement | 1.33e-03 | 8 | 207 | 2 | EFO_0021169 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 1.33e-03 | 8 | 207 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | generalized anxiety disorder (implicated_via_orthology) | 1.33e-03 | 8 | 207 | 2 | DOID:14320 (implicated_via_orthology) | |
| Disease | melanocyte protein PMEL measurement | 1.33e-03 | 8 | 207 | 2 | EFO_0801792 | |
| Disease | common bile duct neoplasm (is_marker_for) | 1.33e-03 | 8 | 207 | 2 | DOID:4608 (is_marker_for) | |
| Disease | schizophrenia (implicated_via_orthology) | 1.35e-03 | 68 | 207 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | triglycerides to phosphoglycerides ratio | 1.35e-03 | 68 | 207 | 4 | EFO_0022327 | |
| Disease | cholesterol in very large HDL measurement | 1.42e-03 | 69 | 207 | 4 | EFO_0022229 | |
| Disease | Cocaine-Related Disorders | 1.44e-03 | 117 | 207 | 5 | C0236736 | |
| Disease | Alcoholic Intoxication | 1.45e-03 | 32 | 207 | 3 | C0001969 | |
| Disease | cholesteryl esters to total lipids in very small VLDL percentage | 1.58e-03 | 71 | 207 | 4 | EFO_0022259 | |
| Disease | pulse pressure measurement, migraine without aura, susceptibility to, 4 | 1.71e-03 | 9 | 207 | 2 | EFO_0005763, MONDO_0011847 | |
| Disease | Osteitis Deformans | 1.71e-03 | 9 | 207 | 2 | C0029401 | |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 1.71e-03 | 9 | 207 | 2 | C0085548 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.71e-03 | 243 | 207 | 7 | EFO_0004612, EFO_0020944 | |
| Disease | pack-years measurement, systolic blood pressure | 1.73e-03 | 34 | 207 | 3 | EFO_0006335, EFO_0006526 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 1.84e-03 | 74 | 207 | 4 | EFO_0022280 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 2.06e-03 | 127 | 207 | 5 | EFO_0008595, EFO_0020947 | |
| Disease | Cocaine Abuse | 2.06e-03 | 127 | 207 | 5 | C0009171 | |
| Disease | Cannabis Abuse | 2.12e-03 | 10 | 207 | 2 | C0006868 | |
| Disease | Cannabis-Related Disorder | 2.12e-03 | 10 | 207 | 2 | C0236735 | |
| Disease | Hashish Abuse | 2.12e-03 | 10 | 207 | 2 | C0018614 | |
| Disease | level of Triacylglycerol (51:3) in blood serum | 2.12e-03 | 10 | 207 | 2 | OBA_2045163 | |
| Disease | dry eye syndrome (is_marker_for) | 2.12e-03 | 10 | 207 | 2 | DOID:10140 (is_marker_for) | |
| Disease | Hypertensive disease | 2.30e-03 | 190 | 207 | 6 | C0020538 | |
| Disease | cholesteryl ester measurement | 2.34e-03 | 257 | 207 | 7 | EFO_0010351 | |
| Disease | free cholesterol in large HDL measurement | 2.34e-03 | 79 | 207 | 4 | EFO_0022157 | |
| Disease | Unipolar Depression | 2.44e-03 | 259 | 207 | 7 | C0041696 | |
| Disease | Moderate albuminuria | 2.45e-03 | 80 | 207 | 4 | HP_0012594 | |
| Disease | very low density lipoprotein cholesterol measurement | 2.50e-03 | 260 | 207 | 7 | EFO_0008317 | |
| Disease | monocyte count | RIN3 ADGRV1 ITGA4 ONECUT1 PTH1R SLC39A8 OR2K2 PI4KA NLRC5 MS4A14 MS4A6A ZYG11A TTF2 RASA3 ZYG11B TSPAN32 MLXIPL GYPE ACKR1 | 2.50e-03 | 1320 | 207 | 19 | EFO_0005091 |
| Disease | bitter alcoholic beverage consumption measurement | 2.52e-03 | 133 | 207 | 5 | EFO_0010092 | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 2.58e-03 | 11 | 207 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | platelet component distribution width | RIN3 SLFN14 SLC39A8 TOX4 HERC1 RNF145 ADGRF1 RASA3 ABCC5 CUBN RHCE MLXIPL CUX1 | 2.74e-03 | 755 | 207 | 13 | EFO_0007984 |
| Disease | essential tremor | 2.77e-03 | 136 | 207 | 5 | EFO_0003108 | |
| Disease | glycine measurement | 2.86e-03 | 137 | 207 | 5 | EFO_0009767 | |
| Disease | Cutaneous Melanoma | 2.98e-03 | 41 | 207 | 3 | C0151779 | |
| Disease | cortical surface area measurement | DCHS2 RELN RIN3 CNNM2 ADAM15 ADGRV1 SLC39A8 PKHD1 FNIP2 NCAPD3 STRN3 HTR1D FAT3 ORC5 GYPE PLEKHM3 CD180 CUX1 EPHA4 | 3.07e-03 | 1345 | 207 | 19 | EFO_0010736 |
| Disease | brain disease (is_implicated_in) | 3.09e-03 | 12 | 207 | 2 | DOID:936 (is_implicated_in) | |
| Disease | Congenital myopathy (disorder) | 3.09e-03 | 12 | 207 | 2 | C0270960 | |
| Disease | complex trait | 3.14e-03 | 271 | 207 | 7 | EFO_0010578 | |
| Disease | Proteinuria | 3.42e-03 | 43 | 207 | 3 | C0033687 | |
| Disease | Kidney Diseases | 3.47e-03 | 88 | 207 | 4 | C0022658 | |
| Disease | squamous cell carcinoma, multiple keratinocyte carcinoma susceptibility measurement, basal cell carcinoma | 3.63e-03 | 13 | 207 | 2 | EFO_0000707, EFO_0004193, EFO_0007932 | |
| Disease | osteitis deformans | 3.63e-03 | 13 | 207 | 2 | EFO_0004261 | |
| Disease | FVC change measurement, response to placebo | 3.63e-03 | 13 | 207 | 2 | EFO_0008344, EFO_0010339 | |
| Disease | illegal drug consumption | 3.63e-03 | 13 | 207 | 2 | EFO_0005431 | |
| Disease | hip geometry | 3.65e-03 | 44 | 207 | 3 | EFO_0004685 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 3.65e-03 | 145 | 207 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | triglyceride measurement, phospholipid measurement | 3.76e-03 | 146 | 207 | 5 | EFO_0004530, EFO_0004639 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 3.89e-03 | 45 | 207 | 3 | EFO_0022236 | |
| Disease | metachronous colorectal adenoma | 3.89e-03 | 45 | 207 | 3 | EFO_0803377 | |
| Disease | serum IgG glycosylation measurement | SLC46A2 LINC02906 VPS13C CFAP92 LBP FRY TMEM132D ERCC6L2 CSMD1 EPHA4 | 4.04e-03 | 523 | 207 | 10 | EFO_0005193 |
| Disease | uric acid measurement | CNNM2 SWT1 ADGRV1 SLC39A8 FAT3 PPM1K MLXIP CUBN AQP1 MLXIPL MUC1 | 4.06e-03 | 610 | 207 | 11 | EFO_0004761 |
| Disease | homocysteine measurement | 4.14e-03 | 46 | 207 | 3 | EFO_0004578 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 4.21e-03 | 150 | 207 | 5 | EFO_0004611, EFO_0020947 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GILTTILQLRETESS | 121 | A4D1N5 | |
| SLSTSVLVSLTVFLL | 266 | Q05901 | |
| GIVSLSDILQALVLT | 311 | P54619 | |
| STIQSSSIILLDTLL | 451 | P41595 | |
| SLEVITLSVNSISTL | 41 | O43822 | |
| QLPSSIVSTGSILTL | 106 | Q96PZ7 | |
| LLNILSGLSVSTEGS | 436 | Q8WWZ4 | |
| GVVSLSDILQALVLS | 466 | Q9UGI9 | |
| EVTLTASLGTLNTLA | 226 | Q8NHY0 | |
| LSLENLGTTTTVQLL | 721 | Q96Q42 | |
| ASVVSILSNISSLSL | 346 | Q5T601 | |
| TQLKATSSLTTGLLL | 686 | Q13444 | |
| TSSLTTGLLLSLLVL | 691 | Q13444 | |
| ETILGLTQGSVSDLL | 1151 | P39880 | |
| GLLLTTNQSLLLELT | 266 | Q49SQ1 | |
| TEGQVLSTITLTILA | 3711 | Q8WXG9 | |
| IVATAILSGITSSLT | 106 | P29972 | |
| ILTSVLGILASSTVL | 66 | Q16570 | |
| LIESESLSSLTNILD | 321 | Q9ULG3 | |
| ETLLLLDVGLTSTLV | 246 | Q8N6Q3 | |
| LLQTVGSLEVLILSS | 491 | Q99467 | |
| VSVSVSTLSLVAIAL | 136 | P32239 | |
| ETIVSALTALSNVSL | 81 | Q9GZT6 | |
| SLSSVETLLTNIQGL | 451 | Q96NX9 | |
| QLSTSIAALTLISLA | 706 | P98194 | |
| QLSTSISALSLITLS | 736 | O75185 | |
| LGVVTAATSLITTLA | 201 | O94973 | |
| ATLLTSGTTATVALL | 181 | Q8N3J5 | |
| SITGNLTLITITLLD | 36 | Q96RD1 | |
| SVTGNLTIITLTLVD | 36 | Q9NZP2 | |
| TLTLISKTVQTLGSL | 511 | Q14644 | |
| LLLGSNIGTTTTALL | 416 | Q8N130 | |
| LVSGSNVLETAVILL | 86 | Q01726 | |
| ILLVTSDVLTISGTI | 356 | Q9GZU1 | |
| LLRISTIAEGTLLSV | 1041 | Q7Z5J8 | |
| QTSTIVLTGNLIASL | 1226 | Q7Z5J8 | |
| LRGETLTLQLTTVSL | 16 | E5RJ46 | |
| LQSTVSESTLIALLA | 146 | P19113 | |
| TTLGTIATLSSQVIN | 911 | P51610 | |
| TALLTSVLVTTTNVL | 5661 | Q8WXI7 | |
| TLSLGLLETTGLLAT | 11866 | Q8WXI7 | |
| ITILLSGQTISDISA | 171 | O60500 | |
| LLLTDSSTLLVGGLQ | 161 | Q504Q3 | |
| VALSVISLGSITLVT | 891 | Q8N6Y1 | |
| DSVNSLLSILDVITG | 261 | Q8IY17 | |
| TATLLSQVLAINTTL | 406 | Q5JU00 | |
| GNILIIITVTSDSQL | 41 | P58180 | |
| TTVSLETTNSLLDLL | 181 | Q96EY7 | |
| TLISVSGLLGTLLLI | 216 | Q8NGY0 | |
| TLLGNVLILTAIISS | 36 | Q8NGN7 | |
| TLVGNTLIILLSALD | 36 | O95918 | |
| TLSGNLLIVVTITTS | 36 | Q96R67 | |
| LLIVVTITTSQALSS | 41 | Q96R67 | |
| LVLTDTGDILATILS | 146 | Q7Z418 | |
| ISISVNLLLGSESSG | 136 | P18428 | |
| ILNSLRSLTTVGLSG | 296 | O43300 | |
| GLLDTSLTASVATLL | 106 | Q9HBW0 | |
| RLTLLSAQSLGVSSL | 931 | Q16706 | |
| LSSARGILSLIQSST | 221 | Q9GZY8 | |
| LFISVSVLSSLGIVL | 591 | Q9UBS5 | |
| SALDTITTVALGSLT | 576 | P52732 | |
| GSALVLTIESTLITA | 3361 | Q2LD37 | |
| SLAISTGLLNVLSQL | 1771 | Q15751 | |
| LLLLLTVLTVVTGSG | 11 | P15941 | |
| GTFTSLLLLASTAIL | 16 | Q9GZN4 | |
| STVLLVSVSGSVVLV | 546 | P54764 | |
| SGSVTILTLAAVSLE | 121 | Q5NUL3 | |
| LDGGTTESNLITSLL | 236 | Q86V87 | |
| LANLSLIDLSLSSVT | 56 | Q8NH21 | |
| GNLLIILTVTSDTSL | 41 | Q8NGD3 | |
| EILIVVNSGILSLST | 196 | Q8NGD3 | |
| LTVVTEFILLGLTQS | 6 | Q8IXE1 | |
| SILLDLANTTGTVTA | 531 | A2RU67 | |
| ATTTEVLSSLGQKLL | 201 | Q9H295 | |
| IFVLLLSGIVSISAS | 6 | P15421 | |
| ITISQQLGLELSTVS | 416 | Q9UBC0 | |
| SLSELLEIQLLTDTT | 1396 | Q6KC79 | |
| LDILQTLSLSLSADI | 1011 | P42356 | |
| SSLTASLTNLLVIAV | 111 | Q9UBY5 | |
| IIVLTTTGRSAQLLS | 471 | P30613 | |
| STVTAVSVLLLLLLG | 371 | Q8NCW0 | |
| ILLLVLGSVLSGSAT | 26 | Q96FE5 | |
| NVIETISSLLASVTL | 276 | Q92616 | |
| DITSETSGILQDLLL | 166 | O76027 | |
| ILTIITLEDSSGNLL | 251 | P04637 | |
| LLTLTGNSALVLLAV | 36 | Q8NGU4 | |
| ATSSIIGLIHSLVQL | 146 | Q8NGB8 | |
| LANLSLIDLSLSSVT | 56 | Q8NGA8 | |
| SILTTLSLERGLTAQ | 496 | Q6ZWE6 | |
| TLVLGLVNSTLTIEE | 201 | O75081 | |
| SILGNLTIITLTLLD | 36 | Q8NGE1 | |
| ELLLAASSSLQTEIL | 1351 | A2RRP1 | |
| SVTGNLTIISLTLLD | 36 | A6NM76 | |
| GLTSLTDLVISQNLL | 241 | Q9BTT6 | |
| GLSKSLQLTELTLTQ | 1346 | Q86WI3 | |
| ILENSILGSLVVTVS | 251 | Q9Y5F1 | |
| LITTGLNTTTASVLQ | 251 | P78509 | |
| TVLLGDITLAESTTQ | 386 | Q7Z442 | |
| LLELLSISGSSLKTI | 361 | Q96RW7 | |
| SITGNLTIITLTLLD | 36 | A6NCV1 | |
| LSLSEDALVGSTLVT | 2556 | Q6V1P9 | |
| LLETTANGTLVTTLN | 251 | Q9Y5I3 | |
| LSSSVTLGVLLSNSV | 646 | Q9H158 | |
| LLTVAGNLGIITLTS | 36 | Q8NGG1 | |
| SGNLSIIILIRISSQ | 36 | Q8WZ92 | |
| TSILIANLSLSDTLV | 71 | Q99463 | |
| VLSTLRQLSTSTSIL | 881 | Q9HAP2 | |
| RLDLISIALITTTGL | 1101 | O15440 | |
| ASLVIVSSLLITAVS | 206 | Q8NH40 | |
| TTSSKLQVLLLTDGV | 1361 | O60494 | |
| SGLLISVIRTLSTSD | 21 | Q96A65 | |
| LSGLTTSYILVLELS | 756 | Q08828 | |
| TLSLTSTSDLQSGII | 1541 | P04114 | |
| SLGRQQTLTAILTIL | 736 | Q96CN9 | |
| TVNGILTLTLISLIL | 46 | Q9NZS2 | |
| LTLTLISLILLVSQG | 51 | Q9NZS2 | |
| ISIRGLSNETLLITS | 361 | Q8TD84 | |
| LLSSQAQSLTLLTTV | 496 | Q7Z3S7 | |
| LGQDVLVSSQVSSLL | 1021 | Q9P278 | |
| LIISSLITGLSGLDA | 96 | P43004 | |
| LLSTLLSLISVAISA | 16 | Q7Z4B0 | |
| LLNTSVLLASGVSIT | 131 | P00414 | |
| IGTSVILISAISQST | 1686 | Q8TDW7 | |
| LSSLTTVTITVLDIN | 3216 | Q8TDW7 | |
| TTGLLSLATVTGNLL | 31 | P11229 | |
| LIGSLATTDLLVSIL | 76 | P28221 | |
| VLSLTLGTFTVLENL | 121 | P21554 | |
| LNLGQITTISITATA | 446 | P48664 | |
| ISSLVAITGITFTIL | 116 | Q96JA4 | |
| SSLVGSILSALSALV | 116 | Q9H2W1 | |
| FTIVIISSSLLLGLI | 976 | P13612 | |
| SQLAITSSLISVQLL | 701 | Q14831 | |
| AAILSLSIASVISGI | 161 | Q8NBI2 | |
| VLLLLLLSGDVQSSE | 11 | Q9NPA0 | |
| LTTTDLTLQLFSLLT | 2111 | Q5TBA9 | |
| LENTSVISLLGDTSI | 1441 | Q5T890 | |
| ASVAGAILSLTIISQ | 521 | Q9Y267 | |
| VLGLVLSSEELLTAQ | 31 | A6NKX4 | |
| LISTLGTYNSLLIIS | 356 | O00237 | |
| LTTIIGTSTSLIFLE | 281 | Q9UKG4 | |
| AITTSLPQLGDLTTL | 171 | Q9NSC2 | |
| VVTSTVTTGLNATIL | 306 | P25940 | |
| LLFATQITLGILIST | 96 | P11049 | |
| TESCLVSGTQVLLTL | 261 | O75170 | |
| GIVEIQTLSSLFILL | 571 | Q3ZCN5 | |
| SVTGNLIIITLTLSD | 36 | A6NL08 | |
| LTAQVASLTSELTTL | 496 | Q14980 | |
| LFTLTLQLTQTLGLE | 106 | Q9GZY1 | |
| QLVILATTTTDLGVT | 716 | Q8TB24 | |
| LTTLLGNSTLILITI | 36 | Q8NGT1 | |
| GNSTLILITILDSRL | 41 | Q8NGT1 | |
| AILSTIDLALSTTSV | 66 | Q8NH60 | |
| GLIVLTVSISKSLDS | 41 | Q8NGF8 | |
| LANLSLIDLSLSSVT | 56 | Q96R69 | |
| LISETLLSSLVSSNT | 86 | Q9H195 | |
| ATATTTLTSLAQLLG | 436 | Q96S52 | |
| NKSLTTLGLVISSLA | 276 | Q9H1H9 | |
| LALGVSSSLIVQAVT | 96 | Q9H720 | |
| ILTLSAIATLDRIGT | 156 | Q9H720 | |
| ETLLFTSSLILTLNT | 176 | Q8WU17 | |
| LILDSSLIAGSSITT | 1126 | A6NKG5 | |
| SLIAGSSITTAITQL | 1131 | A6NKG5 | |
| TSLGASVLVGLSLLL | 741 | Q8NBS3 | |
| SLVILSSQVDSGLQS | 666 | Q13033 | |
| NLGIVSVTSTDISSL | 391 | Q7Z2T5 | |
| VQTGSILSTLTSLDA | 201 | Q96HV5 | |
| QALVVVSLSSRSLLS | 546 | P0C7P3 | |
| NILSSTSGLFTLILA | 271 | Q8WV83 | |
| LTSSLIGTLALSLTI | 421 | Q8WV83 | |
| DSIIVTLSLVELGLA | 646 | P35499 | |
| TDLGVQLVTGLSLSL | 666 | Q14C87 | |
| RANISTGLSLTTIII | 56 | A0A494BZU4 | |
| LLTTGSLRVSEQTLQ | 496 | O43426 | |
| LLGLVTISLATLTAA | 301 | Q96NR3 | |
| TISLATLTAAGIINL | 306 | Q96NR3 | |
| TVLGNLLIILAVSSD | 56 | Q6IFN5 | |
| FSQITSLVTLQLLTL | 381 | O43913 | |
| RLTLGNTTSSVILTN | 66 | P00797 | |
| TPLTTLNTDISILSL | 101 | Q02363 | |
| TGLSTLSKNILTLIE | 1556 | Q96Q15 | |
| TVEELGATLTSLLAQ | 2481 | P58107 | |
| LTVEELGATLTSLLA | 3016 | P58107 | |
| TLTVEELGATLTSLL | 3546 | P58107 | |
| LTVEELGATLTSLLA | 4081 | P58107 | |
| TVEELGATLTSLLAQ | 4616 | P58107 | |
| LQAISEGVGTSLLST | 526 | Q9Y6Q9 | |
| ISLSSSGVLLNGSLV | 341 | Q9UIU6 | |
| SSSLSVLEGQSLRLV | 261 | Q9Y286 | |
| TLSLLLLVTSVTLLV | 11 | Q14108 | |
| LSTNTSGSLTTVLIR | 1491 | P08F94 | |
| NSGLSILLESIVSDL | 571 | Q5T5J6 | |
| IVASTASSVALILLL | 121 | Q92537 | |
| LNSLRQLGTSTSILT | 816 | Q9NP71 | |
| TLTHISVGEVLNILS | 211 | Q96J65 | |
| LTLLGNLLIISTVLS | 36 | Q8NGC5 | |
| LLLSLTLDGLTGVSQ | 176 | P78383 | |
| LDLVISLVGSVSSSA | 391 | Q495N2 | |
| SLVGSVSSSALALII | 396 | Q495N2 | |
| VLSSGITDISLLQTE | 281 | Q5VX52 | |
| STLTGTQVLLLVASE | 176 | P11831 | |
| TSLSIVLSTVASIRL | 301 | P78381 | |
| VLSLLGSIFSLSVIA | 111 | Q01718 | |
| ISSQLSSVLSILDSL | 1271 | Q9UPV0 | |
| VTSASESILELLINS | 476 | P42695 | |
| VNTTLTILLDDIAGS | 326 | Q9H8M5 | |
| GLIIDGSTLSLILNS | 751 | Q8NB49 | |
| NLVVGSLTSLLILVT | 31 | Q9BU79 | |
| IRTTLLLNSTLTASE | 991 | O94827 | |
| GLSLATLLVATAILS | 151 | P32241 | |
| LDISNTSITDITALL | 191 | Q9C0D3 | |
| SIGELSLAIVIALTS | 366 | P18577 | |
| LSVGSILLVTFASLV | 186 | P20645 | |
| LDLVISLVGSVSSSA | 396 | Q7Z2H8 | |
| SLVGSVSSSALALII | 401 | Q7Z2H8 | |
| SVSLASLTVAVLILA | 196 | Q03431 | |
| LSTILTLGITALYTI | 171 | A0PJK1 | |
| ISGLIVNISTSLIAV | 491 | P30825 | |
| QVASSLTSIGLALTV | 196 | Q96QS1 | |
| LTSIGLALTVSALLF | 201 | Q96QS1 | |
| TLITAGGTTLILANI | 726 | Q02447 | |
| SSLIRATIGILITTI | 101 | O14787 | |
| TFLLVSGSLASVLIS | 196 | Q9BXP2 | |
| TVLESSPILTLLNES | 471 | Q9NZV5 | |
| QLVGSLAILSTEVSV | 486 | Q9HBX9 | |
| LLSVTVTSITGLSIS | 176 | P55017 | |
| LVASIGDTTSSLLKI | 596 | Q709C8 | |
| LLLVTLGSLAIILTS | 341 | Q8TCU3 | |
| TILILSVAVLLSTAA | 26 | M5A8F1 | |
| LVELGLSSTFSTILT | 581 | Q14997 | |
| SQSVIVSGIQVLLTL | 261 | Q9UPN7 | |
| TDTINSLIGIGIALS | 446 | Q92536 | |
| VSLLFTTVTTLLTIL | 631 | Q9H330 | |
| VTLGSLTAESQELLT | 61 | Q9UJL9 | |
| SSELSGLVNTISILK | 816 | Q86YA3 | |
| LQLSLALTGVVTSTL | 411 | Q9BY10 | |
| GFATSLSIILSTLIS | 271 | Q9Y2D2 | |
| CTLSLLQGLSTSIAI | 326 | Q9C0K1 | |
| LLTGLISFSTASIII | 121 | Q5TAH2 | |
| ALTLLSSVQGLQSIS | 371 | A5PLN9 | |
| SSILTSLQVLGTLFI | 416 | Q96MT1 | |
| LTSALNITLESSILL | 271 | Q8NG68 | |
| LLFSLQISLIGTTLG | 6 | P0DTE4 | |
| DISNTLVTDISALLT | 211 | Q6WRX3 | |
| LTTIDQSELSSQLGL | 141 | O94842 | |
| LRLSSSQGTIETSLQ | 506 | Q9UHD2 | |
| GLVLSLEEQLSALTL | 946 | Q9UNY4 | |
| SEGILSLVVSLVLSS | 171 | Q9NYW5 | |
| LVLVVTGLSVSVTSL | 51 | Q12918 |